EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

One Year of Exercise After Weight Loss Increases Postprandial GLP ‐1 Secretion in Contrast to Usual Activity or GLP ‐1 Receptor Agonist Treatment

Joachim Holt iD, Rasmus Michael Sandsdal, Sarah Byberg, Charlotte Janus, Christian Rimer Juhl, Julie Rehné Jørgensen, Bolette Hartmann, Bente Stallknecht, Jens Juul Holst, Sten Madsbad iD, Simon Birk Kjær Jensen, Signe Sørensen Torekov iD

Obesity · 2026

DOI: 10.1002/oby.70043 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift Obesity, 2026. Verfasst von Joachim Holt und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Exercise, Glucagon-Like Peptide 1, Glucagon-Like Peptide-1 Receptor Agonists, Liraglutide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk, Cambridge Weight Plan, Helsefonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Incretin‐based obesity medication maintains weight loss by mimicking the appetite‐inhibiting hormone GLP‐1. Interestingly, chronic exercise may improve postprandial appetite control by increasing late postprandial secretion of endogenous GLP‐1. Therefore, we investigated whether an exercise program after weight loss could increase late‐phase postprandial GLP‐1 secretion.

Methods

This study is an exploratory analysis of adults with obesity ( n = 195) who lost 13.1 kg on a low‐calorie diet and were randomized to 52 weeks of either usual activity, moderate‐to‐vigorous intensity exercise, the GLP‐1 receptor agonist liraglutide (3.0 mg/day), or the combination. The primary endpoint was change in late‐phase GLP‐1 response to a 3‐h liquid mixed meal test before and after diet‐induced weight loss and after 1 year of intervention.

Results

Diet‐induced weight loss did not change late‐phase GLP‐1 response (3%; 95% CI, −4%–10%). One year of exercise increased late‐phase postprandial GLP‐1 response within the group by 37% (95% CI, 20%–57%), and this increase was 25% greater (95% CI, 3%–51%, p = 0.02) compared to the usual activity group. Late‐phase postprandial GLP‐1 response was unchanged in both groups treated with GLP‐1 receptor agonist compared to placebo.

Conclusions

One year of exercise increased late‐phase postprandial GLP‐1 response, which may prevent increased appetite after weight loss and thereby weight regain. Trial Registration EudraCT number: 2015–005585‐32; ClinicalTrials.gov identifier: NCT04122716

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExerciseGlucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor AgonistsLiraglutideObesityWeight LossAdultFemaleHumansMaleMiddle AgedGlucagon-Like Peptide-1 ReceptorPostprandial Period

Stichwörter der Autor:innen

GLP‐1appetite regulationexerciseobesityweight loss

Substanzen

Glucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide-1 Receptor AgonistsLiraglutide

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • NNF Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Endocrinology, Hvidovre University Hospital, Copenhagen, Denmark.

ORCID-Profile: Joachim Holt, Sten Madsbad, Signe Sørensen Torekov

Förderung

  • Novo Nordisk
  • Cambridge Weight Plan
  • Helsefonden
  • Danish Cardiovascular Academy
  • Novo Nordisk Fonden

Zitieren

APA

Holt, J., Sandsdal, R. M., Byberg, S., Janus, C., Juhl, C. R., Jørgensen, J. R., Hartmann, B., Stallknecht, B., Holst, J. J., Madsbad, S., Jensen, S. B. K., & Torekov, S. S. (2026). One Year of Exercise After Weight Loss Increases Postprandial GLP ‐1 Secretion in Contrast to Usual Activity or GLP ‐1 Receptor Agonist Treatment. Obesity. https://doi.org/10.1002/oby.70043

Vancouver

Holt J, Sandsdal RM, Byberg S, Janus C, Juhl CR, Jørgensen JR, et al. One Year of Exercise After Weight Loss Increases Postprandial GLP ‐1 Secretion in Contrast to Usual Activity or GLP ‐1 Receptor Agonist Treatment. Obesity. 2026. doi:10.1002/oby.70043

BibTeX
@article{Holt2026,
  author = {Holt, Joachim and Sandsdal, Rasmus Michael and Byberg, Sarah and Janus, Charlotte and Juhl, Christian Rimer and Jørgensen, Julie Rehné and Hartmann, Bolette and Stallknecht, Bente and Holst, Jens Juul and Madsbad, Sten and Jensen, Simon Birk Kjær and Torekov, Signe Sørensen},
  title = {One Year of Exercise After Weight Loss Increases Postprandial GLP ‐1 Secretion in Contrast to Usual Activity or GLP ‐1 Receptor Agonist Treatment},
  journal = {Obesity},
  year = {2026},
  doi = {10.1002/oby.70043}
}
Kostenlos starten →